714 related articles for article (PubMed ID: 21457438)
1. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
Borkham-Kamphorst E; Drews F; Weiskirchen R
Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.
Borkham-Kamphorst E; van de Leur E; Zimmermann HW; Karlmark KR; Tihaa L; Haas U; Tacke F; Berger T; Mak TW; Weiskirchen R
Biochim Biophys Acta; 2013 May; 1832(5):660-73. PubMed ID: 23376114
[TBL] [Abstract][Full Text] [Related]
3. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.
Meng F; Wang K; Aoyama T; Grivennikov SI; Paik Y; Scholten D; Cong M; Iwaisako K; Liu X; Zhang M; Österreicher CH; Stickel F; Ley K; Brenner DA; Kisseleva T
Gastroenterology; 2012 Sep; 143(3):765-776.e3. PubMed ID: 22687286
[TBL] [Abstract][Full Text] [Related]
5. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
6. The role of lipocalin-2 in liver regeneration.
Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H
Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147
[TBL] [Abstract][Full Text] [Related]
7. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling.
Meurer SK; Tihaa L; Borkham-Kamphorst E; Weiskirchen R
Cell Signal; 2011 Apr; 23(4):683-99. PubMed ID: 21146604
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
10. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
[TBL] [Abstract][Full Text] [Related]
11. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.
Kizu T; Yoshida Y; Furuta K; Ogura S; Egawa M; Chatani N; Hamano M; Takemura T; Ezaki H; Kamada Y; Nishida K; Nakaoka Y; Kiso S; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G613-24. PubMed ID: 25617348
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
[TBL] [Abstract][Full Text] [Related]
13. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.
Abella V; Scotece M; Conde J; Gómez R; Lois A; Pino J; Gómez-Reino JJ; Lago F; Mobasheri A; Gualillo O
Biomarkers; 2015; 20(8):565-71. PubMed ID: 26671823
[TBL] [Abstract][Full Text] [Related]
14. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
15. (Z)2-(5-(4-methoxybenzylidene)-2, 4-dioxothiazolidin-3-yl) acetic acid protects rats from CCl(4) -induced liver injury.
Wang ZL; Deng CY; Zheng H; Xie CF; Wang XH; Luo YF; Chen ZZ; Cheng P; Chen LJ
J Gastroenterol Hepatol; 2012 May; 27(5):966-73. PubMed ID: 21913985
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
17. The roles of lipocalin-2 in small-for-size fatty liver graft injury.
Cheng Q; Ng KT; Xu A; Li CX; Liu XB; Guo DY; Poon RT; Fan ST; Lo CM; Man K
Ann Surg; 2014 Dec; 260(6):1062-72. PubMed ID: 24374540
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin 2 Upregulation Protects Hepatocytes from IL1-β-Induced Stress.
Hu Y; Xue J; Yang Y; Zhou X; Qin C; Zheng M; Zhu H; Liu Y; Liu W; Lou G; Wang J; Wu S; Chen Z; Chen F
Cell Physiol Biochem; 2015; 36(2):753-62. PubMed ID: 26021263
[TBL] [Abstract][Full Text] [Related]
19. HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Koh SA; Lee KH
Oncol Rep; 2015 Oct; 34(4):2179-87. PubMed ID: 26259977
[TBL] [Abstract][Full Text] [Related]
20. Serum Lipocalin2 is a potential biomarker of liver irradiation damage.
Sultan S; Cameron S; Ahmad S; Malik IA; Schultze FC; Hielscher R; Rave-Fränk M; Hess CF; Ramadori G; Christiansen H
Liver Int; 2013 Mar; 33(3):459-68. PubMed ID: 23331620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
